NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today reported financial results for 2013 and its financial outlook for 2014.
NPS reported net global product sales of $15.3 million for the fourth quarter of 2013 and $31.8 million for the full year.
Help employers find you! Check out all the jobs and post your resume.
